![evaluate the pharmaceuticals company saxenda on glp-1 medications Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in United States Glucagon-Like Peptide-1 (GLP-1) Agonists: Decreasing](https://photos.prnewswire.com/prnfull/20150421/200096)
evaluate the pharmaceuticals company saxenda on glp-1 medications
Shipping Estimate
evaluate the pharmaceuticals company saxenda on glp-1 medications Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in United States Glucagon-Like Peptide-1 (GLP-1) Agonists: Decreasing
EUR25.34
EUR64.34
Pay in 4 interest-free payments of $6.33 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
![evaluate the pharmaceuticals company saxenda on glp-1 medications Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States Glucagon-Like Peptide-1 (GLP-1) Agonists: Decreasing](https://missouripoisoncenter.org/wp-content/uploads/2024/12/iStock-2025836701-1.webp)
![evaluate the pharmaceuticals company saxenda on glp-1 medications Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States Glucagon-Like Peptide-1 (GLP-1) Agonists: Decreasing](https://cdn.prod.website-files.com/64a1c1af2226015c257c6a0d/6807a3118f39583eb6f85635_How%20to%20Find%20a%20Health%20Plan%20That%20Covers%20GLP-1%20Medications%20-%20Blog%20-%20Extra%20Images%20.png)
![evaluate the pharmaceuticals company saxenda on glp-1 medications Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States Glucagon-Like Peptide-1 (GLP-1) Agonists: Decreasing](https://cdn.prod.website-files.com/660dbd9edac735ff882da2d3/665e4131101a210ec529311b_Saxenda%20Pen%201.png)
![evaluate the pharmaceuticals company saxenda on glp-1 medications Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States Glucagon-Like Peptide-1 (GLP-1) Agonists: Decreasing](https://news.uga.edu/wp-content/uploads/2026/06/06152026_BattleoftheGLP1s_leadimage-1024x769.jpg)
![evaluate the pharmaceuticals company saxenda on glp-1 medications Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States Glucagon-Like Peptide-1 (GLP-1) Agonists: Decreasing](https://media.post.rvohealth.io/wp-content/uploads/sites/3/2024/05/2394973-What-to-know-about-GLP-1-medications-for-weight-loss-Ozempic-Saxenda-and-more-732x549-Feature.jpg)
